Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

United Therapeutics (UTHR) Shares Outstanding (Weighted Average) (2016 - 2026)

United Therapeutics' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $44.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 1.99% to $44.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.3 million, a 1.99% decrease, with the full-year FY2025 number at $44.3 million, down 1.99% from a year prior.
  • Shares Outstanding (Weighted Average) hit $44.3 million in Q4 2025 for United Therapeutics, up from $43.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for UTHR hit a ceiling of $47.0 million in Q1 2024 and a floor of $43.8 million in Q3 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $45.4 million across 5 years, with a median of $45.2 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 3.53% in 2023 and later fell 4.47% in 2025.
  • Tracing UTHR's Shares Outstanding (Weighted Average) over 5 years: stood at $44.9 million in 2021, then grew by 1.34% to $45.5 million in 2022, then rose by 2.86% to $46.8 million in 2023, then decreased by 3.42% to $45.2 million in 2024, then dropped by 1.99% to $44.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for UTHR at $44.3 million in Q4 2025, $43.8 million in Q3 2025, and $45.1 million in Q2 2025.